Stay updated on Pembrolizumab in Untreated B-Cell NHL Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.

Latest updates to the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page
- Check3 days agoChange DetectedThe page now shows a revised tag, updating from v3.6.3 to v3.6.4, indicating a minor site update. This does not alter study details or how the page operates.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, representing a small update to the page metadata.SummaryDifference0.1%

- Check31 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2, indicating an internal update to the page. This does not modify the displayed study information, eligibility criteria, or results.*SummaryDifference0.1%

- Check45 days agoChange DetectedThe study page now includes a recruitment status note indicating recruitment is closed ('No longer looking for participants'), and adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) with an updated Intervention/Treatment label. The previous label 'Intervention / Treatment' and the older 'Revision: v3.5.5' are removed and replaced with 'Revision: v3.6.0'.SummaryDifference0.6%

- Check52 days agoChange DetectedRevision: v3.5.5 appears to replace v3.5.4 in the page metadata, signaling a small update to the page's revision history.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page shows a new revision number (v3.5.4) replacing v3.5.3, indicating a small site update. This change affects metadata rather than any study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Untreated B-Cell NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.